JTCS KCI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Narutoshi Hibino
Yuji Naito
Toshiharu Shinoka
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hibino, N.
Right arrow Articles by Shinoka, T.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Hibino, N.
Right arrow Articles by Shinoka, T.
Related Collections
Right arrow Congenital - acyanotic

J Thorac Cardiovasc Surg 2010;139:431-436
© 2010 The American Association for Thoracic Surgery


Evolving Technology/Basic Science

Late-term results of tissue-engineered vascular grafts in humans

Narutoshi Hibino, MD, PhDa,*, Edward McGillicuddy, MDa, Goki Matsumura, MD, PhDb, Yuki Ichihara, MDb, Yuji Naito, MD, PhDa, Christopher Breuer, MDa, Toshiharu Shinoka, MD, PhDa

a Yale University School of Medicine, Section of Cardiac Surgery, New Haven, Conn
b Tokyo Women's Medical University, Tokyo, Japan

Received for publication April 30, 2009; revisions received September 14, 2009; accepted for publication September 29, 2009.

* Address for reprints: Narutoshi Hibino, MD, PhD, Yale School of Medicine, Section of Cardiac Surgery, 333 Cedar St, Boardman 204, PO Box 208039, New Haven, CT 06520. (Email: narutoshi.hibino{at}yale.edu).

Objective: The development of a tissue-engineered vascular graft with the ability to grow and remodel holds promise for advancing cardiac surgery. In 2001, we began a human trial evaluating these grafts in patients with single ventricle physiology. We report the late clinical and radiologic surveillance of a patient cohort that underwent implantation of tissue-engineered vascular grafts as extracardiac cavopulmonary conduits.

Methods: Autologous bone marrow was obtained and the mononuclear cell component was collected. Mononuclear cells were seeded onto a biodegradable scaffold composed of polyglycolic acid and {epsilon}-caprolactone/L-lactide and implanted as extracardiac cavopulmonary conduits in patients with single ventricle physiology. Patients were followed up by postoperative clinic visits and by telephone. Additionally, ultrasonography, angiography, computed tomography, and magnetic resonance imaging were used for postoperative graft surveillance.

Results: Twenty-five grafts were implanted (median patient age, 5.5 years). There was no graft-related mortality (mean follow-up, 5.8 years). There was no evidence of aneurysm formation, graft rupture, graft infection, or ectopic calcification. One patient had a partial mural thrombosis that was successfully treated with warfarin. Four patients had graft stenosis and underwent successful percutaneous angioplasty.

Conclusion: Tissue-engineered vascular grafts can be used as conduits in patients with single ventricle physiology. Graft stenosis is the primary mode of graft failure. Further follow-up and investigation for the mechanism of stenosis are warranted.



Abbreviations and Acronyms CT = computed tomography; MRI = magnetic resonance imaging; TCPC = total cavopulmonary connection; TEVG = tissue-engineered vascular graft





This article has been cited by other articles:


Home page
GutHome page
G. Orlando, J. D. Bendala, T. Shupe, C. Bergman, K. N. Bitar, C. Booth, M. Carbone, K. L. Koch, J. P. Lerut, J. M. Neuberger, et al.
Cell and organ bioengineering technology as applied to gastrointestinal diseases
Gut, January 20, 2012; (2012) gutjnl-2011-301111v1.
[Abstract] [Full Text]


Home page
FASEB J.Home page
J. K. Harrington, H. Chahboune, J. M. Criscione, A. Y. Li, N. Hibino, T. Yi, G. A. Villalona, S. Kobsa, D. Meijas, D. R. Duncan, et al.
Determining the fate of seeded cells in venous tissue-engineered vascular grafts using serial MRI
FASEB J, December 1, 2011; 25(12): 4150 - 4161.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
N. Hibino, T. Yi, D. R. Duncan, A. Rathore, E. Dean, Y. Naito, A. Dardik, T. Kyriakides, J. Madri, J. S. Pober, et al.
A critical role for macrophages in neovessel formation and the development of stenosis in tissue-engineered vascular grafts
FASEB J, December 1, 2011; 25(12): 4253 - 4263.
[Abstract] [Full Text] [PDF]


Home page
Eur J Cardiothorac SurgHome page
S. Nemoto, H. Ozawa, T. Sasaki, T. Katsumata, K. Kishi, K. Okumura, and Y. Mori
Repair of persistent truncus arteriosus without a conduit: sleeve resection of the pulmonary trunk from the aorta and direct right ventricle-pulmonary artery anastomosis
Eur J Cardiothorac Surg, September 1, 2011; 40(3): 563 - 570.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
N. Hibino, G. Villalona, N. Pietris, D. R. Duncan, A. Schoffner, J. D. Roh, T. Yi, L. W. Dobrucki, D. Mejias, R. Sawh-Martinez, et al.
Tissue-engineered vascular grafts form neovessels that arise from regeneration of the adjacent blood vessel
FASEB J, August 1, 2011; 25(8): 2731 - 2739.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2010 by The American Association for Thoracic Surgery.